Evidence map›Paper›PMID 42049869›Full record

ArticleScientific reports2026

Immunomodulatory effect of borax on murine hepatocellular carcinoma induced by diethylnitrosamine.

Hang Qian, Jin-Ke Yi, Can Zou, Jing-Jian Liu, Hui-Min Huang, Jin-Jin Wang, Ying Wei

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hang Qian *Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine, Cardiovascular medicine, Shiyan, 442008, Hubei, China.
Jin-Ke Yi *Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Rehabilitation department, Shiyan, 442008, Hubei, China.
Can Zou *Department of gastroenterology, The First People's Hospital of Jiangxia District, Hubei University of Medicine, Wuhan, 430200, Hubei, China.
Jing-Jian LiuSinopharm Dongfeng General Hospital, Hubei University of Medicine, Experiment center of medicine, Shiyan, 442008, Hubei, China.
Hui-Min HuangSinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine, Cardiovascular medicine, Shiyan, 442008, Hubei, China.
Jin-Jin Wang *Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Experiment center of medicine, Shiyan, 442008, Hubei, China. 262479669@qq.com.
Ying Wei *Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Experiment center of medicine, Shiyan, 442008, Hubei, China. 57729968@qq.com.

Funding

the Natural Science Foundation of Hubei Provincial Department Grant No. 2025AFB548the Open Project of Hubei Clinical Research Center of Hypertension Grant No. HBCH2024005the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine Grant No. WDCM2024023the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine Grant No. WDCM2024024the Science and Technology Foundation of Shiyan City Grant No. 25Y161the Science and Technology Foundation of Shiyan City Grant No. 25Y165the Sinopharm Dongfeng General Hospital Excellence Program Project Grant No. 2023Q05the Sinopharm Dongfeng General Hospital Excellence Program Project Grant No. 2024Y01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BoronDENFoxp3Hepatocellular carcinomaImmunomodulatory

Identifiers

PMID42049869
PMCPMC13316088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.